Monopex (Dexamethasone Phosphate)

Dexamethasone phosphate, the active ingredient in Monopex, is a glucocorticoid presented as a sterile ophthalmic solution for ocular use. It reduces inflammation and immune responses in the eye, helping manage post‑operative inflammation, uveitis, and allergic conjunctivitis.

GNH USA supplies Monopex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for eye care professionals across multiple regions. Monopex is shipped under controlled conditions to maintain sterility and potency.

Monopex, a glucocorticoid ophthalmic solution, is used to treat inflammatory conditions of the eye.

- Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery. - Uveitis: suppresses intra‑ocular inflammation and helps preserve visual acuity. - Allergic conjunctivitis: alleviates itching, redness and tearing caused by allergic reactions.

Ocular administration of dexamethasone phosphate may be associated with a range of adverse reactions.

Common Side Effects: - Increased intraocular pressure: transient rise that may require monitoring. - Blurred vision: temporary visual disturbance after instillation. - Eye irritation or burning sensation: mild discomfort at the application site. - Tearing or excessive lacrimation. - Conjunctival hyperemia: mild redness of the eye.

Serious or Rare Side Effects: - Cataract formation: accelerated lens opacity with prolonged use. - Secondary ocular infection: bacterial or fungal infection due to immunosuppression. - Severe allergic reaction: swelling, erythema, or anaphylaxis. - Glaucoma: sustained elevation of intraocular pressure. - Retinal detachment: rare but vision‑threatening event. - Systemic adrenal suppression: unlikely but possible with extensive use.

Before prescribing Monopex, clinicians should consider several precautionary measures.

- Screen for glaucoma: assess intraocular pressure before and during therapy. - Avoid in viral ocular infections: steroids may exacerbate viral replication. - Use with caution in diabetic patients: steroids can affect blood glucose control. - Monitor for cataract development during prolonged therapy. - Store at room temperature below 25°C: keep in the original container, protect from light and moisture.

Dexamethasone phosphate can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression. - Anticholinergic eye drops: may reduce the anti‑inflammatory efficacy of the steroid. - NSAID eye drops: combined use can increase risk of corneal melting.

Moderate Interactions (Monitor Closely): - Antiviral eye medications: concurrent use may require monitoring for infection progression. - Beta‑blocker eye drops: potential additive effect on intraocular pressure. - Cyclosporine eye drops: may alter local immunosuppressive balance and require observation.